LKT LABORATORIES

L-type Ca2+ channel blocker and dopamine D2 receptor antagonist. It acts as a FIASMA, suppresses stimulant-induced locomotor activity, and limits seizure development. (C003B-254878)

Cinnarizine is an inhibitor of L-type voltage-gated Ca2+ channels that is clinically used to treat migraine and vertigo. Cinnarizine exhibits anticonvulsant/antiepileptic activity in combination with other therapies in animal models.

Description

Cinnarizine is an inhibitor of L-type voltage-gated Ca2+ channels that is clinically used to treat migraine and vertigo. Cinnarizine exhibits anticonvulsant/antiepileptic activity in combination with other therapies in animal models. This compound also inhibits D2 receptors, suppressing stimulant-induced locomotor activity, and acts as a functional inhibitor of acid sphingomyelinase (FIASMA).

Specifications

UPC:

51171807

Condition:

New

Weight:

1.00 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

C3251-10 g

CAS:

298-57-7

Controlled Substances and Cyanide:

Yes